J3299 HCPCS Level II code: Injection, triamcinolone acetonide (xipere), 1 mg
J3299 is the HCPCS code for “Injection, triamcinolone acetonide (xipere), 1 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J3299Injection, triamcinolone acetonide (xipere), 1 mg
Short description: Inj xipere 1 mg
HCPCS · United States
Medicare details
The indicators CMS publishes with J3299 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care
- BETOS category
- Other drugs
- Added
- Jul 1, 2022
Where J3299 sits
- 1J codesDrugs administered other than orally
- 2Active code J3299Injection, triamcinolone acetonide (xipere), 1 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J3299 mean?
J3299 is the HCPCS code for “Injection, triamcinolone acetonide (xipere), 1 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J3299?
CMS lists J3299’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J3299
All J codesJ3265Injection, torsemide, 10 mg/mlJ3268Injection, delafloxacin, 1 mgJ3280Injection, thiethylperazine maleate, up to 10 mgJ3285Injection, treprostinil, 1 mgJ3290Injection, tranexamic acid, 5 mgJ3291Injection, tranexamic acid in sodium chloride, 5 mgJ3300Injection, triamcinolone acetonide (triesence), preservative free, 1 mgJ3301Injection, triamcinolone acetonide, not otherwise specified, 10 mgJ3302Injection, triamcinolone diacetate, per 5 mgJ3303Injection, triamcinolone hexacetonide, per 5 mgJ3304Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mgJ3305Injection, trimetrexate glucuronate, per 25 mg